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Essential contribution of tumor necrosis factor receptor (TNF-R) 
p55-mediated signals in metastasis and carcinogenesis 
 
Y. Tomita, X. Yang, H. Kitakata, B.K. Popivanova, Y. Nemoto-Sasaki and N. Mukaida 
 
We have previously demonstrated that TNF-Rp55-mediated signals could up-regulate the 
expression of an adhesion molecule, vascular adhesion molecule (VCAM)-1 in sinusoidal 
endothelial cells and eventually facilitate liver metastasis by intrasplenic injection of a colon 
carcinoma cell line into mice (1). 
Intravenous injection of a mouse renal carcinoma cell line, Renca, caused a large number of 
lung metastasis foci in wild-type mice, with TNF-α protein at tumor sites. Metastasis foci 
expanded at similar rates in both wild-type and TNF-Rp55-deficient mice until 21 days after the 
injection. On the contrary, later than 21 days, metastasis foci regressed spontaneously in 
TNF-Rp55-deficient mice, but not wild-type mice. Concomitantly, the number of apoptotic 
tumor cells were greater in TNF-Rp55-deficient mice, whereas neovascularization was less 
evident in TNF-Rp55-deficient mice than wild-type mice, with depressed expression of a potent 
angiogenic factor, hepatocyte growth factor gene in TNF-Rp55-deficient mice (2) (see below 
Figure). These observations implied that TNF-Rp55-mediated signals have distinct but 
important roles in metastasis to liver and lung. 
 
Mice developed multiple adenomatous lesions in colon after repeated oral intake of dextran 
sulfate sodium solution, following an intraperitoneal injection of a potent chemical carcinogen, 
azoxymethane. The same treatment caused few adenomatous lesions in TNF-Rp55-deficient 
mice. Because this model may recapitulate adenocarcinoma developed in patients with chronic 
ulcerative colitis, TNF-Rp55 may be a good molecular target for preventing this severe 
complication in chronic colitis. 
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